![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 16, 12497-12500, April 20, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and
From the Section of Molecular Biology, 0347, and
Center for Molecular Genetics, University of California, San Diego, La
Jolla, California 92093-0347
To study the mechanisms by which
deacetylases regulate transcription by RNA polymerase II, we
investigated the biochemical properties of purified recombinant
Drosophila histone deacetylase 1 (dHDAC1, also known as
dRPD3). We found that purified dHDAC1 and Gal4-dHDAC1 polypeptides
possess substantial deacetylase activity. Thus, deacetylation by dHDAC1
does not require any additional cofactors. Gal4-dHDAC1, but not dHDAC1,
was observed to repress transcription in vitro by about
2-3-fold from chromatin templates, but not from naked DNA templates,
in a Gal4 site-dependent manner. This magnitude of
repression is similar to that commonly seen by deacetylases in
vivo, as assessed by treatment of cells with deacetylase
inhibitors. Transcriptional repression by Gal4-dHDAC1 was blocked by
the deacetylase inhibitor, FR901228, and thus, deacetylase activity
correlates with repression. Single round transcription analyses showed
that Gal4-dHDAC1 reduces the absolute number of productive initiation
complexes with chromatin templates. Moreover, with chromatin templates
that were assembled with completely purified components, Gal4-dHDAC1
was found to deacetylate nucleosomal histones as well as to repress
transcription. These experiments provide biochemical evidence for the
requirement of chromatin for transcriptional repression by dHDAC1 and
further show that dHDAC1 acts to repress the transcription initiation process.
Fellow of The Leukemia & Lymphoma Society.
§
To whom correspondence should be addressed: Section of Molecular
Biology, 0347, Pacific Hall, Rm. 2212B, University of California, San
Diego, 9500 Gilman Dr., La Jolla, CA 92093-0347. Tel.: 858-534-4608; Fax: 858-534-0555; E-mail: jkadonaga@ucsd.edu.
This article has been cited by other articles:
![]() |
S. Bilodeau, S. Vallette-Kasic, Y. Gauthier, D. Figarella-Branger, T. Brue, F. Berthelet, A. Lacroix, D. Batista, C. Stratakis, J. Hanson, et al. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes & Dev., October 15, 2006; 20(20): 2871 - 2886. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Byrd, G. Marcucci, M. R. Parthun, J. J. Xiao, R. B. Klisovic, M. Moran, T. S. Lin, S. Liu, A. R. Sklenar, M. E. Davis, et al. A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia Blood, February 1, 2005; 105(3): 959 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. H. Parsons, S. N. Garcia, L. Pillus, and J. T. Kadonaga Histone deacetylation by Sir2 generates a transcriptionally repressed nucleoprotein complex PNAS, February 18, 2003; 100(4): 1609 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jepsen and M. G. Rosenfeld Biological roles and mechanistic actions of co-repressor complexes J. Cell Sci., February 15, 2002; 115(4): 689 - 698. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |